Iteos Therapeutics 

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31
Revenue
$35,000
$0
$-11,303
Gross Profit
34,691
-303
-11,536
EBITDA
-12,441
-47,232
-30,336
EBIT
-12,751
-47,535
-30,569
Net Income
-7,128
-38,216
-30,551
Net Change In Cash
35,000
0
-11,303
Free Cash Flow
-34,369
-33,345
-15,161
Cash
251,098
146,648
251,177
Basic Shares
39,699
35,843
35,838

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$12,595
$267,630
$344,775
$0
Gross Profit
11,697
266,817
344,160
-535
EBITDA
-151,101
148,377
257,079
-37,841
EBIT
-151,999
147,564
256,464
-38,376
Net Income
-112,642
96,652
214,521
-38,033
Net Change In Cash
12,595
267,630
344,775
0
Cost of Revenue
-555,271
512,381
316,464
Free Cash Flow
-106,722
-112,131
511,959
-25,532
Cash
251,177
284,803
848,537
336,326
Basic Shares
35,763
37,766
37,774
35,044

Earnings Calls

Quarter EPS
2024-09-30
-$1.05
2024-06-30
-$0.18
2024-03-31
-$1.07
2023-12-31
-$0.85